Skip to main content

Research Repository

Advanced Search

The new coronavirus disease: What do we know so far? (2020)
Journal Article
Tang, S., Brady, M., Mildenhall, J., Rolfe, U., Bowles, A., & Morgan, K. (2020). The new coronavirus disease: What do we know so far?. Journal of Paramedic Practice, 12(5), 193-201. https://doi.org/10.12968/jpar.2020.12.5.193

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that causes the new disease COVID-19. Symptoms range from mild to severe with a higher incidence of severe cases in patients with risk factors such as older age and c... Read More about The new coronavirus disease: What do we know so far?.

Effect of formulation variables on oral grittiness and preferences of multiparticulate formulations in adult volunteers (2016)
Journal Article
Lopez, F. L., Bowles, A., Gul, M. O., Clapham, D., Ernest, T. B., & Tuleu, C. (2016). Effect of formulation variables on oral grittiness and preferences of multiparticulate formulations in adult volunteers. European Journal of Pharmaceutical Sciences, 92, 156-162. https://doi.org/10.1016/j.ejps.2016.07.006

© 2016 The Authors Multiparticulate formulations are composed of multiple solid dosage units which can be administered directly to the mouth or sprinkled on food. Oral grittiness (i.e. rough mouthfeel) may arise from the presence of particles in the... Read More about Effect of formulation variables on oral grittiness and preferences of multiparticulate formulations in adult volunteers.

Perception of oral grittiness: Influence of formulation variables (2014)
Presentation / Conference
Lopez, F., Bowles, A., Clapham, D., Ernest, T., Lewis, J., Orlu Gul, M., & Tuleu, C. (2014, September). Perception of oral grittiness: Influence of formulation variables. Poster presented at 6th Conference of the European Paediatric Formulation Initiative (EuPFI) Formulating Better Medicines for Children, Athens, Greece

Development of a Multiparticulate-based Formulation Platform for Delivering Functionalised Capability as an Oral Liquid Dosage (2011)
Presentation / Conference
Bowles, A., Al-Haddad, I., Manghani, S., Ernest, T., Clapham, D., & Tuleu, C. (2011, September). Development of a Multiparticulate-based Formulation Platform for Delivering Functionalised Capability as an Oral Liquid Dosage. Poster presented at 3rd Annual Conference of the European Paediatric Formulation Initiative (EuPFI) Formulating Better Medicines for Children, Strasbourg, France

Influence of viscosity, particle size and particle concentration of suspensions on oral grittiness and acceptability in young adults (2010)
Presentation / Conference
Bowles, A., Al-Haddad, I., Ernest, T., Clapham, D., & Tuleu, C. (2010, November). Influence of viscosity, particle size and particle concentration of suspensions on oral grittiness and acceptability in young adults. Poster presented at International Pharmaceutical Federation World Congress/Annual Meeting American Association of Pharmaceutical Scientists, New Orleans, USA

Application of Multiparticulates for Children’s Medicines (2010)
Presentation / Conference
Bowles, A. (2010, October). Application of Multiparticulates for Children’s Medicines. Presented at 2nd Workshop on Multiparticulate Dosage Forms and Controlled Release Formulations, Binzen (Germany)

Specific aspects of gastro-intestinal transit in children for drug delivery design (2010)
Journal Article
Bowles, A., Keane, J., Ernest, T., Clapham, D., & Tuleu, C. (2010). Specific aspects of gastro-intestinal transit in children for drug delivery design. International Journal of Pharmaceutics, 395(1-2), 37-43. https://doi.org/10.1016/j.ijpharm.2010.04.048

This mini-review discusses relevant aspects of gastro-intestinal transit in different ages of paediatric patients with an attempt to highlight factors which should be considered in oral dosage form design, in particular multi-particulate dosage forms... Read More about Specific aspects of gastro-intestinal transit in children for drug delivery design.


;